Clinical Trials
Roche reports promising Phase II results with new targeted approach in advanced melanoma
Roche announced results from a Phase II clinical study of RG7204 PLX4032), an investigational first-in-class molecule designed to selectively inhibit a cancer-causing, mutated form...
Industry Reports
BioMimetic Therapeutics Reports 2010 Third Quarter Earnings Results
BioMimetic Therapeutics, Inc. reported its financial results as of and for the three and nine months ended September 30, 2010. For the three months...
Production & Manufacturing
Nycomed to acquire of majority stake in Guangdong Techpool Bio-Pharma
Nycomed announced that it is significantly expanding its presence in China through the acquisition of a majority stake in Guangdong Techpool Bio-Pharma Co., Ltd....
News
Eli Lilly to Open a Diabetes-Focused Research Center in China
Eli Lilly and Company announced plans to open a research center focused on diabetes in China, where the incidence of the disease has reached...
Production & Manufacturing
Merck’s Investigational Medicine Boceprevir Achieved Significantly Higher SVR Rates
Merck reported that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, demonstrated significantly higher sustained...
News
Dako and Quintiles form alliance to speed development of personalized medicine
Dako, a Danish-based world leader in tissue-based cancer diagnostics, and Quintiles, the world’s leading bio pharmaceutical services companies, announced a strategic alliance to advance...
Industry Reports
GlaxoSmithKline announced third quarter results-Net Sales growth of 14% compared to the previous quarter
GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the third quarter ended 30th September 2010. The Company has posted a Net Sales growth...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read